Top Nutrition Coaching is fully dedicated to providing its readers with transparent, accurate, and compassionate information that applies to individuals from every demographic. Our nutritionists adhere to specific guidelines when creating content to ensure that all published materials are most advantageous to our readers. Top Nutrition Coaching has a no-tolerance policy regarding plagiarism.
All materials published by Top Nutrition Coaching adhere to the criteria outlined below:
Ozempic and Zepbound use different active ingredients and have different FDA approvals. Here’s how they compare on weight loss, side effects, dosing, and cost, plus what to ask your prescriber.
Ozempic and Zepbound aren’t interchangeable weight loss drugs. They have different ingredients, dosing, eligibility, and potentially side effects.
While Ozempic uses semaglutide and targets one hormone pathway, Zepbound uses tirzepatide and targets two (we’ll dive into what that means exactly).
They also have different FDA-approved uses, so the best choice depends on more than just how much weight you might lose.
Read on to learn how they compare, what the research shows, and what to ask your prescriber before deciding which option makes sense for you.
Here’s a breakdown of all the differences laid out simply:
| Ozempic | Zepbound | |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Manufacturer | Novo Nordisk | Eli Lilly |
| How it works | Activates GLP-1 receptors | Activates GLP-1 and GIP receptors |
| FDA-approved uses |
|
|
| Approved for weight loss? | No; weight loss alone is an off-label use | Yes |
| Average weight loss in head-to-head trials | 13.7% with semaglutide at the Wegovy dose in the SURMOUNT-5 clinical trial | 20.2% with tirzepatide in the SURMOUNT-5 clinical trial |
| Forms | Weekly injection pen and daily oral tablet in the US | Single-dose injection pens, single-dose vials, and multi-dose KwikPen in the US |
| Dosing frequency | Injection: once weekly; tablet: once daily | Once-weekly injection |
| Common side effects | Nausea, vomiting, diarrhea, constipation, abdominal pain | Nausea, diarrhea, vomiting, constipation, abdominal pain |
| Sister brand | Wegovy | Mounjaro |
While most people talk about GLP-1s (glucagon-like peptide-1 receptor agonists) as if they’re all the same, they’re not. Ozempic and Zepbound have different active ingredients and FDA-approved uses. Here’s what to know:
Ozempic uses the active ingredient semaglutide and is approved for people with type 2 diabetes. It’s also FDA-approved to help reduce certain heart and kidney risks in people with type 2 diabetes.
Many get it prescribed off-label (i.e., without a type 2 diabetes diagnosis) thanks to its well-known weight-loss effects. But its sister drug, Wegovy, is the one meant for weight management. They’re both manufactured by Novo Nordisk, but because they’re approved for different uses at different doses, they have different treatment plans and eligibility requirements.
Unlike Ozempic, Zepbound is FDA-approved for weight management in eligible adults. It's also approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.
Zepbound uses the active ingredient tirzepatide just like its sister drug Mounjaro (approved for type 2 diabetes), and both are made by Eli Lilly.
Ozempic works by targeting one hormone pathway, while Zepbound works by targeting two.
They both mimic the gut hormone GLP-1, which helps regulate blood sugar and appetite. The difference is that Zepbound also targets GIP (glucose-dependent insulinotropic polypeptide) — another hormone involved in blood sugar and appetite regulation.
Zepbound acting on two hormonal pathways may help explain why it tends to show greater weight loss. But how much you lose on Ozempic or Zepbound depends on the dose, whether you have type 2 diabetes, and how long you take the medication for.
Two major trials compared tirzepatide with semaglutide, and both found more average weight loss with tirzepatide. But remember, trial averages can’t predict what you’ll specifically lose.
In a 40-week trial, people taking tirzepatide lost an average of 7.6 to 11.2 kg (about 17 to 25 pounds). The difference depended on the dose, but it was still higher when compared to the 5.7 kg loss (about 13 pounds) for those taking semaglutide.
But there’s an important detail: the semaglutide dose in this study was 1 mg (an Ozempic dose), while semaglutide for weight management is dosed higher.
A more recent 72-week trial compared tirzepatide with semaglutide at the higher doses for weight management. People lost an average of 20.2% of their body weight with tirzepatide, compared with 13.7% with semaglutide.
Here, the important detail is that the study used Wegovy, which has the same active ingredient as Ozempic, but it’s used at a higher dose. So, the results don't exactly represent a direct comparison with Ozempic at its usual lower dose.
While the clinical trials show one thing, in real life, people tend not to be as strict. Some don’t take it regularly or stop early because of side effects or cost.
In general, though, tirzepatide still seems to lead to more weight loss. A 2024 study of more than 18,000 adults found that those taking tirzepatide were more likely to achieve significant weight loss than those taking semaglutide over 3, 6, and 12 months.
At one year, the tirzepatide group lost an average of 6.9 percentage points more body weight. The study included people taking formulations used for type 2 diabetes, so its results don't directly compare the highest weight-management doses.
That doesn't automatically make tirzepatide the better choice for everyone, though. Side effects, medical history, cost, and insurance coverage all matter when deciding which medication to take with your prescriber.
Ozempic and Zepbound have a lot in common when it comes to side effects, which tend to mostly be digestive issues. Most people won't experience every side effect, but how well you tolerate a medication matters just as much as how much weight you lose, since many stop taking them because of side effects.
Nausea, diarrhea, constipation, and vomiting are common side effects of GLP-1 medications, and they’re often worse when you start or increase a dose.
To help, try eating smaller meals and drinking enough water. Since you’re eating less, you’ll also want to prioritize nutritionally rich foods, and knowing what to eat when taking GLP-1s can make that easier.
Keep your prescriber up to date on your symptoms, and contact them if you can’t keep fluids down or get serious stomach pain.
Weight loss usually leads to muscle loss, too. For example, research on tirzepatide found that around 25% of weight lost was lean mass.
To help preserve muscle while on GLP-1s, research suggests prioritizing protein and resistance training. Of course, that’s easier said than done. That’s why a registered dietitian (and personal trainer) can not only help hold you accountable but also help you build healthy habits that last even after you stop the medication.
Many insurance plans cover nutrition counseling with a registered dietitian, whether or not you’re on a GLP-1, though coverage varies by plan.
Both medications have an FDA boxed warning about thyroid C-cell tumors observed in rodents. Neither should be used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).
There are other serious risks as well, including pancreatitis, acute kidney injury, serious allergic reactions, low blood sugar, and gallbladder problems.
Both medications should be discussed with your prescriber if you're pregnant or planning a pregnancy. Zepbound can also make birth control pills less effective, so ask your prescriber about backup contraception. Because they slow stomach emptying, they can also increase the risk of aspiration (inhaling food or liquid into the lungs) during anesthesia or deep sedation. Always tell your healthcare team before any procedure.
In the US, Ozempic has two options: a weekly injection or a daily pill. The injections come in prefilled pens.
Zepbound is a weekly injection available in single-dose pens, single-dose vials, and multi-dose KwikPens. Storage requirements are often different, so check the prescribing instructions.
Sometimes people switch because of side effects, a new diagnosis, or insurance coverage. However, switching has to be done under the care of your prescriber.
Ozempic and Zepbound aren’t meant to be taken together. Their doses aren't interchangeable, so your prescriber has to create a plan for how and when to switch. You might need to gradually increase the new medication's dose, and digestive side effects may return.
What you'll pay for Ozempic or Zepbound depends on your insurance, prescription, and eligibility for savings programs.
Insurance coverage: Ozempic is usually covered for type 2 diabetes, and Zepbound for weight management and certain adults with obesity and sleep apnea. Coverage varies by plan, and many insurance plans don’t cover weight-loss treatment.
Savings and cash-pay options: With eligibility and commercial insurance, you might be able to use a manufacturer savings card. If you're paying out of pocket, official programs offer discounted cash prices.
As of October 2026, Ozempic injection offers start at $349 per month after any introductory offer, while Zepbound self-pay options start at $299 per month for the starting dose. Remember that prices change as your dose increases, and using injectables can come with added costs.
Also, pricing and eligibility are constantly changing, so check the official Ozempic and Zepbound savings pages for current options.
Neither medication is right for everyone. Your health history, weight-loss goals, side effects, and insurance coverage all matter. Points to consider:
Before deciding, ask your prescriber:
One thing that tends to come with finally seeing weight loss after years of struggle is a boost in momentum. You might be thrilled not just to see clothes fitting better, but to have more mental space. You might find you’re spending less time thinking about what you ate or will eat.
You can take advantage of that space and momentum to build in healthy eating and exercise habits — because once you stop taking the medication, appetite often returns. But if you develop habits and set things in place, you may be able to limit weight regain and stay on the path to an overall healthier lifestyle.
Don’t forget that you’ll also be eating less, which makes it easy to develop nutritional deficiencies. On top of that, muscle is lost along with fat, so getting enough protein is key.
A registered dietitian specializing in weight loss can help you define your habits and create a lifestyle that works for you. Your prescriber is there to manage your prescription and symptoms, while a dietitian can offer GLP-1 nutrition support that sets you up for long-term success.
Find out if you’re covered for nutrition counseling with Top Nutrition Coaching today.
Based on current Top Nutrition Coaching client experience, more than 90% of clients have insurance plans that provide coverage for appointments with registered dietitians; however, coverage is not guaranteed.
Clinical trials show Zepbound leading to more weight loss on average than semaglutide, the active ingredient in Ozempic. However, it’s different for everyone — and fast weight loss isn’t always what’s best.
Yes, weight regain is common because appetite returns after stopping the medications. Research shows people who stopped semaglutide regained about 67% of the weight they’d lost within one year. That’s part of why seeing a registered dietitian to develop a healthier lifestyle with support is so important.
Yes, your prescriber might recommend switching if it suits your needs and goals. They shouldn’t be taken together, and your prescriber will have to determine your new starting dose and treatment plan.
All GLP-1s can come with nausea, diarrhea, constipation, and vomiting, especially when you increase your dosage. It’s hard to say which one could affect you more, since everyone reacts differently. Talk to your prescriber about any side effects you experience.
Every insurer has their own rules, and most won’t cover off-label use (i.e., without the proper diagnosis). Ozempic is FDA-approved for type 2 diabetes and certain risk-reduction indications. Zepbound is approved for chronic weight management and obstructive sleep apnea in eligible adults with obesity. You’ll have to check directly with your insurer about coverage for your specific diagnosis.




